These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24587336)

  • 41. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
    Schulz TF; Cesarman E
    Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.
    Gloghini A; Volpi CC; Gualeni AV; Dolcetti R; Bongarzone I; De Paoli P; Carbone A
    Expert Rev Hematol; 2017 Jun; 10(6):505-514. PubMed ID: 28468596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?
    Lambe JS; Oble DA; Nandula SV; Sevilla DW; Colovai AI; Mansukhani M; Chari A; Murty VV; Alobeid B; Bhagat G
    Hematol Oncol; 2009 Dec; 27(4):203-10. PubMed ID: 19337983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
    Qin Z; Dai L; Trillo-Tinoco J; Senkal C; Wang W; Reske T; Bonstaff K; Del Valle L; Rodriguez P; Flemington E; Voelkel-Johnson C; Smith CD; Ogretmen B; Parsons C
    Mol Cancer Ther; 2014 Jan; 13(1):154-64. PubMed ID: 24140934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.
    Gopalakrishnan R; Matta H; Chaudhary PM
    Clin Cancer Res; 2013 Sep; 19(18):5016-26. PubMed ID: 23881928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effusion and solid lymphomas have distinctive gene and protein expression profiles in an animal model of primary effusion lymphoma.
    Yanagisawa Y; Sato Y; Asahi-Ozaki Y; Ito E; Honma R; Imai J; Kanno T; Kano M; Akiyama H; Sata T; Shinkai-Ouchi F; Yamakawa Y; Watanabe S; Katano H
    J Pathol; 2006 Aug; 209(4):464-73. PubMed ID: 16741895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma.
    Bonsignore L; Passelli K; Pelzer C; Perroud M; Konrad A; Thurau M; Stürzl M; Dai L; Trillo-Tinoco J; Del Valle L; Qin Z; Thome M
    Leukemia; 2017 Mar; 31(3):614-624. PubMed ID: 27538487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases.
    Pringle ES; Wertman J; Melong N; Coombs AJ; Young AL; O'Leary D; Veinotte C; Robinson CA; Ha MN; Dellaire G; Druley TE; McCormick C; Berman JN
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31861850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
    Kalt I; Masa SR; Sarid R
    Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.
    Bhatt S; Ashlock BM; Toomey NL; Diaz LA; Mesri EA; Lossos IS; Ramos JC
    J Clin Invest; 2013 Jun; 123(6):2616-28. PubMed ID: 23635777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.
    Sarosiek KA; Cavallin LE; Bhatt S; Toomey NL; Natkunam Y; Blasini W; Gentles AJ; Ramos JC; Mesri EA; Lossos IS
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13069-74. PubMed ID: 20615981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.
    Brulois KF; Chang H; Lee AS; Ensser A; Wong LY; Toth Z; Lee SH; Lee HR; Myoung J; Ganem D; Oh TK; Kim JF; Gao SJ; Jung JU
    J Virol; 2012 Sep; 86(18):9708-20. PubMed ID: 22740391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases.
    Pan ZG; Zhang QY; Lu ZB; Quinto T; Rozenvald IB; Liu LT; Wilson D; Reddy V; Huang Q; Wang HY; Ren YS
    Am J Surg Pathol; 2012 Aug; 36(8):1129-40. PubMed ID: 22790853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo.
    Towata T; Komizu Y; Suzu S; Matsumoto Y; Ueoka R; Okada S
    Leuk Res; 2010 Jul; 34(7):906-11. PubMed ID: 20074798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
    Viejo-Borbolla A; Schulz TF
    AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter.
    Li H; Komatsu T; Dezube BJ; Kaye KM
    J Virol; 2002 Dec; 76(23):11880-8. PubMed ID: 12414930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
    McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
    Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.
    Sarek G; Kurki S; Enbäck J; Iotzova G; Haas J; Laakkonen P; Laiho M; Ojala PM
    J Clin Invest; 2007 Apr; 117(4):1019-28. PubMed ID: 17364023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KSHV-associated extracavitary primary effusion lymphoma in an HIV seronegative patient: a case report and review of the literature.
    Ibrahim U; Saqib A; Mohammad F; Ding J; Hussein S; Atallah JP
    Postgrad Med; 2017 Apr; 129(3):402-407. PubMed ID: 28122468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus.
    Qin Z; Dai L; Slomiany MG; Toole BP; Parsons C
    Cancer Res; 2010 May; 70(10):3884-9. PubMed ID: 20406987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.